Cryptotanshinone was regarded as the STAT3 and STAT5 regulator for ischemic stroke (Zhu et al., 2021) and chronic myelocytic leukemia (Dong et al., 2018). The gene discussed is STAT5A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.